ESTRO 2025 - Abstract Book

S2302

Interdisciplinary – Health economics & health services research

ESTRO 2025

The methodology was introduced first in the tumour care line for prostate cancer. Trailblazing clinicians, dedicated IT-support and facilitating project managers proved essential for successful deployment in the organization. A real time dashboard (Figure 2) presents the patient-relevant outcomes according to initial patient conditions, enabling thorough analysis of patient subgroups. National (i.e. ProZIB) and international (i.e. ProtecT, CHHiP and PACE-B study) scientific literature on patient-relevant outcome is incorporated in the dashboard and serves as benchmark to evaluate our institute's performance. The dashboard enables our clinicians to analyse the improvement potential and formulate evidence based innovations to further improve our patient outcomes. Currently, we are expanding our program to other tumour care lines to further work towards continuous quality improvement. Conclusion: Our institute’s dedication to continually elevate patient outcomes exemplifies our commitment to deliver VBHC for oncology patients. Our approach serves as a blueprint to scale up our VBHC-program to the network of ten hospitals located in our region to provide the best oncology care for our patients.

Keywords: VBHC, patient-relevant outcomes, PDSA-cycle

References: 1. Porter ME & Lee TH. The Strategy That Will Fix Health Care. Harvard Business Review; 2013 2. Deming WE. Out of the Crisis. MIT Press: Cambridge, Massachusetts; 1982